Table 1.
No. | Author [ref.] | Year | Age (years) | Site | Size (cm) | Grade | Surgical Approach | Lymph node metastasis | Distant Metastasis | Follow-up, (months) | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Present case | 2020 | 42 | Right | 2.6 | LG | MRM | NA | No | 12 | Alive |
2 | Mingfei Yan et al. [14] | 2019 | 60 | Right | 1.9 | LG | lumpectomy | NA | No | 60 | Alive |
3 | Burghel et al. [15] | 2018 | 73 | Left | NA | LG | NA | 0/2 | No | NA | NA |
4 | Sherwell-Cabello et al. [16] | 2017 | 86 | Left | 6 | LG | MRM | NA | No | 3 | Alive |
5 | Cheng et al. [13] | 2017 | 39 | Right | 1.5 | LG | MRM | 3/18 | No | 156 | Alive |
6 | 49 | Left | 1.5 | LG | MRM | 0/17 | No | 41 | Alive | ||
7 | 66 | Left | 1.3 | LG | Mastectomy + SLD | 0/6 (SLD) | No | 9 | Alive | ||
8 | 61 | Left | 3 | LG | Mastectomy + SLD | 0/3 (SLD) | No | 4 | Alive | ||
9 | Fujino et al. [17] | 2016 | 71 | Right | 1.7 | IG | Mastectomy + SLD | 0/NA | No | NA | NA |
10 | Palermo et al. [18] | 2013 | 80 | Right | 4 | HG | NA | 0/NA | No | NA | NA |
11 | Turk et al. [19] | 2013 | 40 | Right | 5.5 | NA | MRM | 1/24 | No | 5 | Alive |
12 | Basbug et al. [20] | 2011 | 69 | Left | 10 | HG | MRM | 0/12 | No | 12 | Alive |
13 | Camelo-Piragua et al. [1] | 2009 | 49 | Right | 4 | IG | MRM | 1/3 | No | 8 | Alive |
14 | Hornychova et al. [9] | 2007 | 63 | Right | 1.8 | HG | SM + LND | 0/17 | No | 18 | Alive |
15 | 30 | Left | 8 | LG | MRM | 0/NA | No | 60 | Alive | ||
16 | Horii et al. [21] | 2006 | 54 | Left | 2.5 | LG | Mastectomy + LND | 0/NA | No | 36 | Alive |
17 | Gomez-Aracil et al. [22] | 2006 | 69 | Right | 7.5 | HG | MRM + LND | 24/28 | No | 54 | Alive |
18 | Di Tommaso et al. [23] | 2004 | 80 | Left | 0.5 | LG | Excision | NA | No | 5 | Alive |
19 | 29 | Left | 0.8 | LG | Excision | NA | No | 90 | Alive | ||
20 | 54 | Left | 1.5 | LG | Quadrantectomy + LND | NA | No | 13 | Alive | ||
21 | 55 | Left | 1.1 | IG | Quadrantectomy + LND | NA | No | 3 | Alive | ||
22 | 36 | Left | 0.6 | HG | Quadrantectomy + LND | NA | No | 18 | Alive | ||
23 | Terzi et al. [24] | 2004 | 79 | Right | 8 | HG | MRM | 4/14 | No | NA | NA |
24 | Tjalma et al. [25] | 2002 | 58 | Right | 3.5 | HG | RM | 1/17 | Yes | 156 | Alive |
25 | Berry et al. [26] | 1998 | 51 | Left | 3.5 | HG | Mastectomy + LND | 0/NA | No | NA | NA |
26 | Markopoulos et al. [27] | 1998 | 40 | Right | 2 | HG | Wide local excision + LND | 0/NA | No | 60 | Alive |
27 | Chang et al. [28] | 1998 | 54 | Left | 4.5 | HG | MRM | 0/9 | No | 48 | Alive |
28 | Luchtrath and Moll [29] | 1989 | 60 | NA | 5 | HG | RM | 12/18 | Yes, (bone) | 30 | DOD |
29 | Pettinato et al. [30] | 1989 | 72 | Right | 7 | HG | MRM | 16/19 | Yes, (lung) | 10 | DOD |
30 | Hanna and Kahn [10] | 1985 | 51 | Left | 2 | NA | MRM | 0/NA | No | 8 | Alive |
31 | 31 | NA | NA | NA | MRM | 2/18 | No | 14 | Alive | ||
32 | Hastrup and Sehested [31] | 1985 | 59 | Left | 1 | HG | RM | 0/4 | Yes, (lung and liver) | 25 | DOD |
33 | Leong and Williams [32] | 1985 | 57 | Left | 3.5 | HG | SM | 0/20 | Yes | 7 | DOD |
34 | Ratanarapee et al. [33] | 1983 | 27 | NA | NA | HG | NA | 6/15 | Yes | 14 | DOD |
35 | Fisher et al. [8] | 1983 | 65 | Right | 2 | LG | Lumpectomy | NA | No | 60 | Alive |
36 | 71 | Left | 2 | LG | MRM | 0/19 | No | 48 | Alive | ||
37 | 57 | Right | 2.5 | LG | MRM | 0/11 | No | 120 | Alive | ||
38 | 49 | Right | 3.7 | LG | RM | 0/13 | No | 108 | Alive | ||
39 | 60 | Left | 4 | LG | SM | NA | No | 48 | Alive | ||
40 | Kovi et al. [34] | 1981 | 46 | Left | 11 | HG | MRM | 17/19 | NA | NA | NA |
41 | Patchefsky et al. [7] | 1979 | 66 | Right | 1.3 | LG | RM | 0/20 | No | 94 | DOR |
42 | 70 | Right | 5 | LG | Quadrantectomy | NA | No | 10 | Alive |
Abbreviations: LG = low grade; HG = high grade; IG = intermediate grade; MRM = modified radical mastectomy; SLD = sentinel lymph node; DOD = died of disease; DOR = died of other reasons; SM = simple mastectomy; RM = radical mastectomy; LND = lymph node dissection; NA = not applicable.